Sasco Capital’s Pediatrix Medical MD Stock Holding History

Sasco Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-144,100	Closed	-$1.67M	–	23
2024 Q3	$1.67M	Hold	144,100	–	–	0.25%	34
2024 Q2	$1.09M	Buy	144,100 +28,480	+25%	+$236K	0.15%	44
2024 Q1	$1.16M	Buy	115,620 +11,010	+11%	+$102K	0.16%	42
2023 Q4	$973K	Hold	104,610	–	–	0.11%	44
2023 Q3	$1.33M	Buy	104,610 +7,040	+7%	+$96.6K	0.17%	38
2023 Q2	$1.39M	Hold	97,570	–	–	0.16%	40
2023 Q1	$1.45M	Buy	97,570 +7,660	+9%	+$116K	0.18%	40
2022 Q4	$1.34M	Buy	89,910 +7,040	+8%	+$115K	0.17%	36
2022 Q3	$1.37M	Hold	82,870	–	–	0.2%	34
2022 Q2	$1.74M	Buy	82,870 +13,870	+20%	+$283K	0.24%	35
2022 Q1	$1.62M	Buy	69,000 +27,090	+65%	+$663K	0.2%	36
2021 Q4	$1.14M	Buy	41,910 +32,590	+350%	+$872K	0.13%	42
2021 Q3	$265K	Hold	9,320	–	–	0.03%	43
2021 Q2	$281K	Hold	9,320	–	–	0.03%	45
2021 Q1	$237K	Buy	+9,320	New	+$239K	0.03%	45

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Sasco Capital's MD Position: Q4 2024 in Review

Sasco Capital sold out of Pediatrix Medical (MD) in Q4 2024, closing a stake of 144,100 shares — an estimated $1.67M sold.

Sasco Capital first reported a position in MD in Q1 2021 and held it in 15 quarters. The position peaked at $1.74M in Q2 2022. 229 funds tracked by Wall St. Rank hold MD as of Q4 2024.

Sasco Capital reported no remaining Pediatrix Medical position as of Q4 2024 after selling out during the quarter.
Sasco Capital sold 144,100 Pediatrix Medical shares in Q4 2024, an estimated $1.67M.
Sasco Capital first reported a position in Pediatrix Medical in Q1 2021 and held it in 15 quarters.
Sasco Capital's Pediatrix Medical position peaked at $1.74M in Q2 2022.
229 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2024.

Based on Sasco Capital's 13F filing for Q4 2024.